On July 17, 2025, an expert panel convened by the FDA reviewed the risks and benefits of hormone therapy for menopause. And ...

President Donald Trump is expected have his administration move to reclassify marijuana as a less dangerous drug, according ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental ...

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with ...

Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...

Despite increased labeling of drugs with pediatric information, most medicines remain available only as pills meant for ...

Federal, state, and private actions are accelerating across color additives, labeling and packaging, heavy metals, ultraprocessed foods, and ...

The vast majority of what we do would be eliminated if people fix their diet,” says cardiologist Kim Allan Williams Sr.

Democratic senators have introduced a new bill to create a federal regulatory framework for hemp-derived cannabinoids and ...